Shimizu M, Iwaguchi T
Department of Cancer Therapeutics, Tokyo Metropolitan Institute of Medical Science, Japan.
Cancer Immunol Immunother. 1994 Apr;38(4):272-6. doi: 10.1007/BF01533519.
The function of T cell subsets in tumor-bearing mice was examined using an in vitro culture system of anti-(sheep red blood cell) antibody production, which is known to be dependent on T cells. The helper function of T cells of fibrosarcoma-MethA-bearing mice in antibody production decreased with the tumor stage of the mice. T cells were separated into CD4+ and CD8+ cells for further analysis of T cell subsets by the panning method using monoclonal antibodies. The helper function of CD4+ T cells in antibody production began to decrease significantly in tumor-bearing mice 1 week after the tumor transplantation. On the other hand, the suppressive function of CD8+ T cells was retained and had not decreased in the mice even 3 weeks after the transplantation. The same changes in function of CD4+ and CD8+ T cells were also observed in Meth1-bearing mice. These results suggested that this tumor-associated immunosuppression in antibody production is attributable to the decrease in helper activity of CD4+ T cells and the maintenance of the suppressive activity of CD8+ T cells.
利用已知依赖于T细胞的抗(绵羊红细胞)抗体产生的体外培养系统,检测了荷瘤小鼠中T细胞亚群的功能。荷纤维肉瘤-MethA小鼠的T细胞在抗体产生中的辅助功能随着小鼠肿瘤分期的增加而降低。使用单克隆抗体通过淘选法将T细胞分离为CD4+和CD8+细胞,以进一步分析T细胞亚群。荷瘤小鼠在肿瘤移植后1周,CD4+ T细胞在抗体产生中的辅助功能开始显著下降。另一方面,CD8+ T细胞的抑制功能得以保留,甚至在移植后3周小鼠体内也未下降。在荷Meth1小鼠中也观察到了CD4+和CD8+ T细胞功能的相同变化。这些结果表明,抗体产生中这种肿瘤相关的免疫抑制归因于CD4+ T细胞辅助活性的降低和CD8+ T细胞抑制活性的维持。